251 related articles for article (PubMed ID: 7407756)
1. Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors.
Levin VA; Edwards MS; Wright DC; Seager ML; Schimberg TP; Townsend JJ; Wilson CB
Cancer Treat Rep; 1980; 64(2-3):237-44. PubMed ID: 7407756
[TBL] [Abstract][Full Text] [Related]
2. BCNU-5-fluorouracil combination therapy for recurrent malignant brain tumors.
Levin VA; Hoffman WF; Pischer TL; Seager ML; Boldrey EB; Wilson CB
Cancer Treat Rep; 1978 Dec; 62(12):2071-6. PubMed ID: 221113
[TBL] [Abstract][Full Text] [Related]
3. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
[TBL] [Abstract][Full Text] [Related]
4. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
[TBL] [Abstract][Full Text] [Related]
5. BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumors.
Levin VA; Crafts DC; Wilson CB; Schultz MJ; Boldrey EB; Enot KJ; Pischer TL; Seager M; Elashoff RM
Cancer Treat Rep; 1976 Mar; 60(3):243-9. PubMed ID: 177210
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine.
Crafts DC; Levin VA; Edwards MS; Pischer TL; Wilson CB
J Neurosurg; 1978 Oct; 49(4):589-92. PubMed ID: 690688
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of malignant glioma with CCNU alone and CCNU combined with vincristine sulfate and procarbazine hydrochloride.
Shapiro WR; Young DF
Trans Am Neurol Assoc; 1976; 101():217-20. PubMed ID: 1028239
[No Abstract] [Full Text] [Related]
8. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma.
Yang SH; Hong YK; Yoon SC; Kim BS; Lee YS; Lee TK; Lee KS; Jeun SS; Kim MC; Park CK
Oncol Rep; 2007 Jun; 17(6):1359-64. PubMed ID: 17487391
[TBL] [Abstract][Full Text] [Related]
9. Nitrosourea chemotherapy for primary malignant gliomas.
Levin VA; Wilson CB
Cancer Treat Rep; 1976 Jun; 60(6):719-24. PubMed ID: 954010
[No Abstract] [Full Text] [Related]
10. [Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma].
Bouffet E; Mornex F; Jouvet A; Thiesse P; Mertens P; Helfre S; Sindou M; Bret P
Bull Cancer; 1997 Oct; 84(10):951-6. PubMed ID: 9435796
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumors.
Gutin PH; Wilson CB; Kumar AR; Boldrey EB; Levin V; Powell M; Enot KJ
Cancer; 1975 May; 35(5):1398-404. PubMed ID: 1122488
[TBL] [Abstract][Full Text] [Related]
12. Combination cytotoxic chemotherapy with CCNU, procarbazine, and vincristine in disseminated cutaneous malignant melanoma: 3 years, followup.
Carmo-Pereira J; Costa FO; Pimentel P; Henriques E
Cancer Treat Rep; 1980 Jan; 64(1):143-5. PubMed ID: 7379048
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)].
Afra D; Sipos L; Vitanovics D
Ideggyogy Sz; 2002 Jan; 55(1-2):38-44. PubMed ID: 12122942
[TBL] [Abstract][Full Text] [Related]
14. PCV chemotherapy for recurrent glioblastoma.
Schmidt F; Fischer J; Herrlinger U; Dietz K; Dichgans J; Weller M
Neurology; 2006 Feb; 66(4):587-9. PubMed ID: 16505319
[TBL] [Abstract][Full Text] [Related]
15. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
Levin VA; Hess KR; Choucair A; Flynn PJ; Jaeckle KA; Kyritsis AP; Yung WK; Prados MD; Bruner JM; Ictech S; Gleason MJ; Kim HW
Clin Cancer Res; 2003 Mar; 9(3):981-90. PubMed ID: 12631596
[TBL] [Abstract][Full Text] [Related]
16. Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas.
Jakacki RI; Jamison C; Mathews VP; Heilman DK; Dropcho E; Cornetta K; Macdonald DR; Williams DA
Med Pediatr Oncol; 1998 Dec; 31(6):483-90. PubMed ID: 9835900
[TBL] [Abstract][Full Text] [Related]
17. Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas.
Kyritsis AP; Yung WK; Jaeckle KA; Bruner J; Gleason MJ; Ictech SE; Flowers A; Levin VA
Neurosurgery; 1996 Nov; 39(5):921-6. PubMed ID: 8905746
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.
Stege EM; Kros JM; de Bruin HG; Enting RH; van Heuvel I; Looijenga LH; van der Rijt CD; Smitt PA; van den Bent MJ
Cancer; 2005 Feb; 103(4):802-9. PubMed ID: 15637687
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and feasibility of procarbazine, ranimustine and vincristine chemotherapy, and the role of surgical resection in anaplastic oligodendroglioma.
Yamamoto M; Iwaasa M; Nonaka M; Tsugu H; Nabeshima K; Fukushima T
Anticancer Res; 2005; 25(6A):3715-23. PubMed ID: 16302731
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy of nonirradiated malignant gliomas. Phase II: study of the combination of methyl-CCNU, vincristine, and procarbazine.
Avellanosa AM; West CR; Tsukada Y; Higby DJ; Bakshi S; Reese PA; Jennings E
Cancer; 1979 Sep; 44(3):839-46. PubMed ID: 225004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
